Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML.
Ivan PasicWaleed Da'naWilson LamArjun LawJeffrey H LiptonAuro ViswabandyaDennis D KimSanthosh ThyaguHans A MessnerFotios V MichelisPublished in: European journal of haematology (2019)
NPM1 and FLT3-ITD status may provide limited prognostic information about transplant outcomes in CN AML patients.
Keyphrases
- acute myeloid leukemia
- allogeneic hematopoietic stem cell transplantation
- bone marrow
- end stage renal disease
- ejection fraction
- newly diagnosed
- stem cell transplantation
- single cell
- prognostic factors
- cell therapy
- low dose
- lymph node metastasis
- acute lymphoblastic leukemia
- patient reported outcomes
- health information
- weight loss